Accelovance named "Best CRO"

Wednesday, April 20, 2011 11:33 AM

Accelovance, a privately held CRO, has been named the “Best Contract Research Organization (CRO)” for a third consecutive year. The World Vaccine Congress hosted its annual Vaccine Industry Excellence (ViE) Awards to honor and generate recognition of the efforts, accomplishments, and positive contributions of companies and individuals in the vaccine industry over the past 12 months.

“Quality and commitment are what define our organization,” remarked Lee Barsky, vice president of CRO services at Accelovance. “It is equally rewarding to see how our diverse service offering helps sponsors maintain growth despite challenging times in the industry.”

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs